Private Wealth Advisors (Pennsylvania)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Private Wealth Advisors (Pennsylvania)’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$25K	Buy	+12,000	New	+$19.8K	0.01%	116

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Private Wealth Advisors (Pennsylvania)'s INFI Position: Q4 2020 in Review

Private Wealth Advisors (Pennsylvania) opened a new position in Infinity Pharmaceuticals, Inc. (INFI) in Q4 2020: 12,000 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #116 among its holdings.

55 funds tracked by Wall St. Rank hold INFI as of Q4 2020.

Private Wealth Advisors (Pennsylvania) held 12,000 shares of Infinity Pharmaceuticals, Inc. worth $25K as of Q4 2020.
Infinity Pharmaceuticals, Inc. was a new Private Wealth Advisors (Pennsylvania) position in Q4 2020.
Infinity Pharmaceuticals, Inc. made up 0.01% of Private Wealth Advisors (Pennsylvania)'s portfolio in Q4 2020, its #116 holding.
55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2020.

Based on Private Wealth Advisors (Pennsylvania)'s 13F filing for Q4 2020, filed 9 Feb 2021.